SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 409 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $209,000 | -54.6% | 2,694 | -56.4% | 0.01% | -60.0% |
| Q1 2021 | $460,000 | -66.1% | 6,177 | -22.4% | 0.02% | -72.7% |
| Q4 2020 | $1,358,000 | +28.4% | 7,964 | +5.7% | 0.06% | +3.8% |
| Q3 2020 | $1,058,000 | +10.8% | 7,532 | +26.4% | 0.05% | +6.0% |
| Q2 2020 | $955,000 | +306.4% | 5,958 | +147.8% | 0.05% | +233.3% |
| Q1 2020 | $235,000 | -17.3% | 2,404 | +9.4% | 0.02% | -16.7% |
| Q4 2019 | $284,000 | +21.4% | 2,197 | +11.9% | 0.02% | +38.5% |
| Q1 2019 | $234,000 | -16.1% | 1,964 | -23.2% | 0.01% | -18.8% |
| Q4 2018 | $279,000 | -36.4% | 2,557 | -5.9% | 0.02% | -5.9% |
| Q3 2018 | $439,000 | – | 2,717 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |